Lower serum PF4 level was observed at diagnosis in MM patients who achieved CR and VGPR after two courses of VAD regimens, and IL-10 has been found to be a powerful predictor of prognosis for MM [51]. The gene discussed is PF4; the disease is Miyoshi myopathy.